Case Study - Mellalta Meets

Skip to the content

support@mellalta.com +1 (304) 470-2225

Home
About Us
Services
Case Studies
Blog
Report Store
Contact Us
- My account
Products search

Menu

Cart

No products in the cart.

View Cart Checkout

Market Assessment Case Study

Market Assessment

Competitive Intelligence Case Study

Competitive Intelligence

Business Partnership Case Study

Business Partnership

Due Diligence & Market Potential-Case Study

Competitive Intelligence, Market Assessment

Latest Case Studies

Market Assessment Case Study

Market Assessment

Competitive Intelligence Case Study

Competitive Intelligence

Business Partnership Case Study

Business Partnership

From Our Store

Prader-Willi Syndrome (PWS)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00
Metastatic Ovarian Cancer (mOC)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00
ER+/HER2- Metastatic Breast Cancer (mBC)| Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2032 $6,500.00 – $19,500.00
Rett Syndrome (RTT) | Primary Research (KOL's Insight) | Competitive Intelligence | Market Analytics & Forecast 2032 $6,500.00 – $19,500.00
Anti-Neutralizing Antibodies (NAbs) Gene Therapies-Pipeline Analytics 2021 $2,500.00 – $7,500.00

Good job you got results!
You guys are the Roger Federer of CI

A Mid Biotech Firm Head of Strategy

Get in touch

Consulting is most often used when a company needs an outside, expert opinion regarding a business decision.

Get In Touch

Let's keep the conversation going

DELIVERING STRATEGIES THAT MAKES THE DIFFERENCE

Mellalta Meets is where imagination meets excellence, we champion the bold and help in achieving companies the extraordinary.

Documents

Fast Facts PDF Document

Financial Information PDF Document

Recent Posts

Menarini’s Upcoming Business Strategies for Elacestrant for Breast Cancer August 30, 2022
Y-mabs’ Danyelza for R/R High-Risk Neuroblastoma: Business & Launch Strategies December 3, 2020

Contact Us

+1 (304) 470-2225
support@mellalta.com

Mellalta Meets - Excellence Reimagined

Copyright 2020